tradingkey.logo
tradingkey.logo
Search

Keros Therapeutics Inc

KROS
Add to Watchlist
10.300USD
+0.220+2.18%
Close 11-13 16:00(ET)
204.25MMarket Cap
LossP/E TTM

Today

+2.18%

5 Days

+10.04%

1 Month

-7.21%

6 Months

-1.90%

Year to Date

-49.41%

1 Year

-40.32%

Key Figures

10.060Open
10.550High
8.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
10.080Prev. Close
9.550Low
86.17KTurnover
LossP/E Static
0.73P/B
0.00%Div Yield TTM
-15.53%ROA
22.55052wk High
0.03Volume Ratio
-187.35MNet Profit
19.83MShares
-2.5301EPS TTM
0.95Beta
-16.79%ROE
8.98052wk Low
11.06%Amplitude
100.00%Gross Margin
204.25MMarket Cap
-1.66Reward/Risk
3.23%Risk Rate
More news coming soon, stay tuned...

Keros Therapeutics Inc's Score

0.02vs previous score
Forecast7.43
Financial Health9.05
Technical4.72
Valuation Dimensions6.75
Institutional Confidence10.00
Risk Assessment4.71

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
19.800Target Price
+79.35%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy11111222
Buy33333333
Hold33444444
Sell00000000
Strong Sell00000000

Keros Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.71/-0.94
Revenue / Forecast
40.01M/14.76M

Keros Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolKROS
Number of employees169
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.9.66%
Arrowstreet Capital, Limited Partnership6.74%
State Street Investment Management (US)5.44%
Vanguard Capital Management, LLC4.20%
Shareholder TypesProportion
Investment Advisor/Hedge Fund36.73%
Investment Advisor31.57%
Hedge Fund27.98%
Research Firm4.75%

FAQs

What is the current price of Keros Therapeutics Inc (KROS)?

The current price of Keros Therapeutics Inc (KROS) is 10.30.

What is the symbol of Keros Therapeutics Inc?

The ticker symbol of Keros Therapeutics Inc is KROS.

What is the 52-week high of Keros Therapeutics Inc?

The 52-week high of Keros Therapeutics Inc is 22.55.

What is the 52-week low of Keros Therapeutics Inc?

The 52-week low of Keros Therapeutics Inc is 8.98.

What is the market capitalization of Keros Therapeutics Inc?

The market capitalization of Keros Therapeutics Inc is 204.25M.

Is Keros Therapeutics Inc (KROS) currently rated as Buy, Hold, or Sell?

According to analysts, Keros Therapeutics Inc (KROS) has an overall rating of Buy, with a price target of 19.80.

What is the Earnings Per Share (EPS TTM) of Keros Therapeutics Inc (KROS)?

The Earnings Per Share (EPS TTM) of Keros Therapeutics Inc (KROS) is -2.53.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.